A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

NCT04761627 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
494
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen